Do intravenous lidocaine for the treatment of background or procedural burn pain?
As current clinical evidence is based on only one single RCT as well as case series and reports, intravenous lidocaine must be considered a pharmacological agent under investigation in burns care, the effectiveness of which is yet to be determined with further well-designed and conducted clinical trials.
Publishing everything is more effective than only reporting significant outcomes.